Abstract
Obesity has become a major public health problem. Given the current increase in life expectancy, the prevalence of obesity also raises steadily among older age groups. The increase in life expectancy is often accompanied with additional years of susceptibility to chronic ill health associated with obesity in the elderly. Both obesity and ageing are conditions leading to serious health problems and increased risk for disease and death. Ageing is associated with an increase in abdominal obesity, a major contributor to insulin resistance and the metabolic syndrome. Obesity in the elderly is thus a serious concern and comprehension of the key mechanisms of ageing and age-related diseases has become a necessary matter. Here, we aimed to identify similarities underlying mechanisms related to both obesity and ageing. We bring together evidence that age-related changes in body fat distribution and metabolism might be key factors of a vicious cycle that can accelerate the ageing process and onset of age-related diseases.
This is a preview of subscription content, access via your institution.
References
Kirkland JL (2013) Translating advances from the basic biology of aging into clinical application. Exp Gerontol 48(1):1–5
Willett WC, Dietz WH, Colditz GA (1999) Guidelines for healthy weight. N Engl J Med 341(6):427–434
Haslam DW, James WP (2005) Obes Lancet 366(9492):1197–1209
Sacks G, Swinburn B, Lawrence M (2009) Obesity policy action framework and analysis grids for a comprehensive policy approach to reducing obesity. Obes Rev: Off J Inter Assoc Stud Obes 10(1):76–86
Yosipovitch G, DeVore A, Dawn A (2007) Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Derm 56(6):901–916 quiz 17-20
Obesity and overweight by WHO Epub http://www.who.int/mediacentre/factsheets/fs311/en/
Miard S, Picard F (2008) Obesity and aging have divergent genomic fingerprints. Int J Obes 32(12):1873–1874
Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61(6):1315–1322
Slawik M, Vidal-Puig AJ (2006) Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev 5(2):144–164
Tchkonia T, Morbeck DE, Von Zglinicki T, Van Deursen J, Lustgarten J, Scrable H, et al. (2010) Fat tissue, aging, and cellular senescence. Aging Cell 9(5):667–684
Ahima RS (2009) Connecting obesity, aging and diabetes. Nat Med 15(9):996–997
Bowen RL, Atwood CS (2004) Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology 50(5):265–290
Roth TN (2015) Aging of the auditory system. Handb Clin Neurol 129:357–373
Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, et al. (2009) Age-associated cognitive decline. Br Med Bull 92:135–152
Masternak MM, Bartke A (2012) Growth hormone, inflammation and aging. Pathobiol Aging Age Relat Dis 2
Starr ME, Evers BM, Saito H (2009) Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A, Biol Sci Med Sci 64(7):723–730
Glatt SJ, Chayavichitsilp P, Depp C, Schork NJ, Jeste DV (2007) Successful aging: from phenotype to genotype. Biol Psychiatry 62(4):282–293
Harrison DE, Archer JR, Astle CM (1984) Effects of food restriction on aging: separation of food intake and adiposity. Proc Natl Acad Sci U S A 81(6):1835–1838
Bartke A (2000) Delayed aging in Ames dwarf mice. Relationships to endocrine function and body size. Results Probl Cell Differ 29:181–202
Anderson RM, Shanmuganayagam D, Weindruch R (2009) Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol 37(1):47–51
Visser M, Pahor M, Tylavsky F, Kritchevsky SB, Cauley JA, Newman AB, et al. (2003) One- and two-year change in body composition as measured by DXA in a population-based cohort of older men and women. J Appl Physiol (1985) 94(6):2368–2374
Kuk JL, Saunders TJ, Davidson LE, Ross R (2009) Age-related changes in total and regional fat distribution. Ageing Res Rev 8(4):339–348
Burt Solorzano CM, McCartney CR (2010) Obesity and the pubertal transition in girls and boys. Reproduction 140(3):399–410
Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S (2011) Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol 57(5):577–585
Huffman DM, Barzilai N (2009) Role of visceral adipose tissue in aging. Biochim Biophys Acta 1790(10):1117–1123
Edwards MG, Anderson RM, Yuan M, Kendziorski CM, Weindruch R, Prolla TA (2007) Gene expression profiling of aging reveals activation of a p53-mediated transcriptional program. BMC Genomics 8:80
Ida H, Boylan SA, Weigel AL, Hjelmeland LM (2003) Age-related changes in the transcriptional profile of mouse RPE/choroid. Physiol Genomics 15(3):258–262
Trayhurn P, Wang B, Wood IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Brit J Nutr 100(2):227–235
Ye J, Gao Z, Yin J, He Q (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293(4):E1118–E1128
Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56(4):901–911
Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66(6):889–900
Valli A, Harris AL, Kessler BM (2015) Hypoxia metabolism in ageing. Aging 7(7):465–466
Genne-Bacon EA (2014) Thinking evolutionarily about obesity. Yale J Biol Med 87(2):99–112
Rosen ED, Spiegelman BM (2014) What we talk about when we talk about fat. Cell 156(1–2):20–44
Avram MM, Avram AS, James WD (2005a) Subcutaneous fat in normal and diseased states: 1. introduction. J Am Acad Dermatol 53(4):663–670
Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, et al. (1998) Life without white fat: a transgenic mouse. Genes Dev 12(20):3168–3181
Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ (2001) The biology of white adipocyte proliferation. Obes Rev: Off J Int Assoc Stud Obes 2(4):239–254
Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C, et al. (2006) Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2(5):e81
Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105(3):271–278
Measuring and Evaluating Body Composition Epub https://www.acsm.org/public-information/articles/2012/01/12/measuring-and-evaluating-body-composition
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA: JAm Med Assoc 289(2):187–193
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359(20):2105–2120
Tchkonia T, Giorgadze N, Pirtskhalava T, Thomou T, DePonte M, Koo A, et al. (2006) Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 55(9):2571–2578
Jiang Y, Zhang Y, Jin M, Gu Z, Pei Y, Meng P (2015) Aged-related changes in body composition and association between body composition with bone mass density by body mass index in Chinese Han men over 50-year-old. PLoS ONE 10(6):e0130400
Mathus-Vliegen EM (2012) Obesity and the elderly. J Clin Gastroenterol 46(7):533–544
Carter S, Caron A, Richard D, Picard F (2013) Role of leptin resistance in the development of obesity in older patients. Clin Interv Aging 8:829–844
Arum O, Boparai RK, Saleh JK, Wang F, Dirks AL, Turner JG, et al. (2014) Specific suppression of insulin sensitivity in growth hormone receptor gene-disrupted (GHR-KO) mice attenuates phenotypic features of slow aging. Aging Cell 13(6):981–1000
Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR, Potter JD, et al. (1993) Body fat distribution and 5-year risk of death in older women. JAMA: J Am Med Assoc 269(4):483–487
De Martinis M, Franceschi C, Monti D, Ginaldi L (2005) Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 579(10):2035–2039
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254
Deleidi M, Jaggle M, Rubino G (2015) Immune aging, dysmetabolism, and inflammation in neurological diseases. Front Neurosci 9:172
Shaw AC, Goldstein DR, Montgomery RR (2013) Age-dependent dysregulation of innate immunity. Nat Rev Immunol 13(12):875–887
Spaulding CC, Walford RL, Effros RB (1997) Calorie restriction inhibits the age-related dysregulation of the cytokines TNF-alpha and IL-6 in C3B10RF1 mice. Mech Ageing Dev 93(1–3):87–94
Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8(3):131–136
Hernandez-Bautista RJ, Alarcon-Aguilar FJ, Del CE-VM, Almanza-Perez JC, Merino-Aguilar H, Fainstein MK, et al. (2014) Biochemical alterations during the obese-aging process in female and male monosodium glutamate (MSG)-treated mice. Int J Mol Sci 15(7):11473–11494
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1):4–12
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808
Ryan AS, Nicklas BJ (2004) Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 27(7):1699–1705
Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Lofgren P, et al. (2010) Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 53(12):2496–2503
Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104(51):20466–20471
Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52(7):1779–1785
Li JB, Nishida M, Kaimoto K, Asakawa A, Chaolu H, Cheng KC, et al. (2014) Effects of aging on the plasma levels of nesfatin-1 and adiponectin. Biomed Rep 2(1):152–156
Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB (2006) Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8(3):264–280
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol: JASN 13(1):134–141
Koh SJ, Hyun YJ, Choi SY, Chae JS, Kim JY, Park S, et al. (2008) Influence of age and visceral fat area on plasma adiponectin concentrations in women with normal glucose tolerance. Clinica Chimica Acta; International Journal of Clinical Chemistry 389(1–2):45–50
Takenouchi Y, Kobayashi T, Matsumoto T, Kamata K (2009) Gender differences in age-related endothelial function in the murine aorta. Atherosclerosis 206(2):397–404
Stenholm S, Koster A, Alley DE, Visser M, Maggio M, Harris TB, et al. (2010) Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol 73(1):55–65
Gulcelik NE, Halil M, Ariogul S, Usman A (2013) Adipocytokines and aging: adiponectin and leptin. Minerva Endocrinol 38(2):203–210
Ukkola O, Santaniemi M (2002) Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med (Berl) 80(11):696–702
Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1(12):1311–1314
Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415(6869):339–343
Scarpace PJ, Tumer N (2001) Peripheral and hypothalamic leptin resistance with age-related obesity. Physiol Behav 74(4–5):721–727
Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. (1995) Identification and expression cloning of a leptin receptor. OB-R Cell 83(7):1263–1271
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1(11):1155–1161
Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, et al. (1996) Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J ClinInvest 97(5):1344–1347
Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girard J, Staels B, et al. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature 377(6549):527–529
Segal KR, Landt M, Klein S (1996) Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45(7):988–991
Zierath JR, Frevert EU, Ryder JW, Berggren PO, Kahn BB (1998) Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 47(1):1–4
Myers MG Jr, Heymsfield SB, Haft C, Kahn BB, Laughlin M, Leibel RL, et al. (2012) Challenges and opportunities of defining clinical leptin resistance. Cell Metab 15(2):150–156
Lonnqvist F, Arner P, Nordfors L, Schalling M (1995) Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1(9):950–953
Li H, Matheny M, Nicolson M, Tumer N, Scarpace PJ (1997) Leptin gene expression increases with age independent of increasing adiposity in rats. Diabetes 46(12):2035–2039
Sanchez-Rodriguez M, Garcia-Sanchez A, Retana-Ugalde R, Mendoza-Nunez VM (2000) Serum leptin levels and blood pressure in the overweight elderly. Arch Med Res 31(4):425–428
Scarpace PJ, Matheny M, Moore RL, Tumer N (2000a) Impaired leptin responsiveness in aged rats. Diabetes 49(3):431–435
Li H, Matheny M, Tumer N, Scarpace PJ (1998) Aging and fasting regulation of leptin and hypothalamic neuropeptide Y gene expression. Am J Physiol 275(3 Pt 1):E405–E411
Petervari E, Rostas I, Soos S, Tenk J, Miko A, Furedi N, et al. (2014) Age versus nutritional state in the development of central leptin resistance. Peptides 56:59–67
Wing RR, Sinha MK, Considine RV, Lang W, Caro JF (1996) Relationship between weight loss maintenance and changes in serum leptin levels. Horm Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme 28(12):698–703
Scarpace PJ, Matheny M, Shek EW (2000b) Impaired leptin signal transduction with age-related obesity. Neuropharmacology 39(10):1872–1879
Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ 3rd, et al. (1997) Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185(1):171–175
Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897–901
Marwarha G, Ghribi O (2012) Leptin signaling and Alzheimer’s disease. Am J Neurodegenerative Disease 1(3):245–265
Short KR, Vittone JL, Bigelow ML, Proctor DN, Nair KS (2004) Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab 286(1):E92–101
Lexell J 1995 Human aging, muscle mass, and fiber type composition. The journals of gerontology Series A, Biological sciences and medical sciences 50 Spec No:11–6
Latorre-Roman PA, Izquierdo-Sanchez JM, Salas-Sanchez J, Garcia-Pinillos F (2015) Comparative analysis between two models of active aging and its influence on body composition, strength levels and quality of life: long-distance runners versus bodybuilders practitioners. Nutr Hosp 31(4):1717–1725
Forbes GB, Welle SL (1983) Lean body mass in obesity. Int J Obes 7(2):99–107
Hulens M, Vansant G, Lysens R, Claessens AL, Muls E, Brumagne S (2001) Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach. Int J Obes Relat Metab Disord: J Int Assoc Stud Obes 25(5):676–681
Masgrau A, Mishellany-Dutour A, Murakami H, Beaufrere AM, Walrand S, Giraudet C, et al. (2012) Time-course changes of muscle protein synthesis associated with obesity-induced lipotoxicity. J Physiol 590(Pt 20):5199–5210
Chanseaume E, Giraudet C, Gryson C, Walrand S, Rousset P, Boirie Y, et al. (2007) Enhanced muscle mixed and mitochondrial protein synthesis rates after a high-fat or high-sucrose diet. Obesity (Silver Spring) 15(4):853–859
Kemp JG, Blazev R, Stephenson DG, Stephenson GM (2009) Morphological and biochemical alterations of skeletal muscles from the genetically obese (ob/ob) mouse. Int J Obes 33(8):831–841
Dube J, Goodpaster BH (2006) Assessment of intramuscular triglycerides: contribution to metabolic abnormalities. Curr Opin Clin Nutr Metab Care 9(5):553–559
Alvim RO, Cheuhen MR, Machado SR, Sousa AG, Santos PC (2015) General aspects of muscle glucose uptake. An Acad Bras Cienc 87(1):351–368
Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2(10):819–829
Tidball JG (2011) Mechanisms of muscle injury, repair, and regeneration. Compr Physiol 1(4):2029–2062
Reich NC, Levine AJ (1984) Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308(5955):199–201
Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene? Genes Dev 4(1):1–8
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307–310
Vousden KH (2002) Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602(1):47–59
Welle S, Brooks AI, Delehanty JM, Needler N, Bhatt K, Shah B, et al. (2004) Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women. Exp Gerontol 39(3):369–377
Yahagi N, Shimano H, Matsuzaka T, Najima Y, Sekiya M, Nakagawa Y, et al. (2003) p53 activation in adipocytes of obese mice. J Biol Chem 278(28):25395–25400
Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, et al. (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15(9):1082–1087
Yokoyama M, Okada S, Nakagomi A, Moriya J, Shimizu I, Nojima A, et al. (2014) Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity. Cell Reports 7(5):1691–1703
Bartke A (1998) Growth hormone and aging. Endocrine 8(2):103–108
Kargi AY, Merriam GR 2000 Age-related changes in the growth hormone axis and growth hormone therapy in the elderly. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, et al., editors. Endotext. South Dartmouth (MA)
Hersch EC, Merriam GR (2008) Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: fountain of youth or pool of tantalus? Clin Interv Aging 3(1):121–129
Sonntag WE, Ramsey M, Carter CS (2005) Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev 4(2):195–212
Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. (1990) Effects of human growth hormone in men over 60 years old. N Eng J Med 323(1):1–6
Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW, Draper MW (1991) Effects of human growth hormone on body composition in elderly men. Horm Res 36(Suppl 1):73–81
Papadakis MA, Grady D, Black D, Tierney MJ, Gooding GA, Schambelan M, et al. (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124(8):708–716
Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. (2007) Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 146(2):104–115
Lubrano C, Tenuta M, Costantini D, Specchia P, Barbaro G, Basciani S, et al. (2015) Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study. Endocrine 49(2):503–511
Gagnon J, Zhu L, Anini Y, Wang Q 2015 Neutralizing circulating ghrelin by expressing a growth hormone secretagogue receptor-based protein protects against high-fat diet-induced obesity in mice. Gene Ther
Schumacher B, van der Pluijm I, Moorhouse MJ, Kosteas T, Robinson AR, Suh Y, et al. (2008) Delayed and accelerated aging share common longevity assurance mechanisms. PLoS Genetics 4(8):e1000161
Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277–359
Kozak LP, Koza RA, Anunciado-Koza R (2010a) Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int J Obes 34(Suppl 1):S23–S27
Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, et al. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2):366–376
Ricquier D (2011) Uncoupling protein 1 of brown adipocytes, the only uncoupler: a historical perspective. Front Endocrinol 2:85
Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360(15):1518–1525
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360(15):1509–1517
Seale P, Lazar MA (2009) Brown fat in humans: turning up the heat on obesity. Diabetes 58(7):1482–1484
Xue B, Coulter A, Rim JS, Koza RA, Kozak LP (2005) Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots. Mol Cell Biol 25(18):8311–8322
Chabowska-Kita A, Trabczynska A, Korytko A, Kaczmarek MM, Kozak LP (2015) Low ambient temperature during early postnatal development fails to cause a permanent induction of brown adipocytes. FASEB J: Off Publ Feder Am Soc Exp Biol 29(8):3238–3252
McDonald RB, Horwitz BA (1999) Brown adipose tissue thermogenesis during aging and senescence. J Bioenerg Biomembr 31(5):507–516
Lin L, Lee JH, Bongmba OY, Ma X, Zhu X, Sheikh-Hamad D, et al. (2014) The suppression of ghrelin signaling mitigates age-associated thermogenic impairment. Aging 6(12):1019–1032
Valle A, Guevara R, Garcia-Palmer FJ, Roca P, Oliver J (2008) Caloric restriction retards the age-related decline in mitochondrial function of brown adipose tissue. Rejuvenation Res 11(3):597–604
Yoneshiro T, Aita S, Matsushita M, Okamatsu-Ogura Y, Kameya T, Kawai Y, et al. (2011) Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring) 19(9):1755–1760
Muzik O, Mangner TJ, Leonard WR, Kumar A, Janisse J, Granneman JG (2013) 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat. J Nucl Med: Off Publ Soc Nucl Med 54(4):523–531
Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 8(11):870–879
Mattson MP (2010) Perspective: does brown fat protect against diseases of aging? Ageing Res Rev 9(1):69–76
Himms-Hagen J, Desautels M (1978) A mitochondrial defect in brown adipose tissue of the obese (ob/ob) mouse: reduced binding of purine nucleotides and a failure to respond to cold by an increase in binding. Biochem Biophys Res Commun 83(2):628–634
Avram AS, Avram MM, James WD (2005b) Subcutaneous fat in normal and diseased states: 2. anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol 53(4):671–683
Vijgen GH, Bouvy ND, Teule GJ, Brans B, Schrauwen P, van Marken Lichtenbelt WD (2011) Brown adipose tissue in morbidly obese subjects. PLoS ONE 6(2):e17247
Claessens-van Ooijen AM, Westerterp KR, Wouters L, Schoffelen PF, van Steenhoven AA, van Marken Lichtenbelt WD (2006) Heat production and body temperature during cooling and rewarming in overweight and lean men. Obesity (Silver Spring) 14(11):1914–1920
van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, et al. (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360(15):1500–1508
Wijers SL, Saris WH, van Marken Lichtenbelt WD (2010) Cold-induced adaptive thermogenesis in lean and obese. Obesity (Silver Spring) 18(6):1092–1099
Collins S, Daniel KW, Petro AE, Surwit RS (1997) Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138(1):405–413
Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP (1998) Emergence of brown adipocytes in white fat in mice is under genetic control. effects on body weight and adiposity. J Clin Invest 102(2):412–420
Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak LP (1995) Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96(6):2914–2923
van der Lans AA, Hoeks J, Brans B, Vijgen GH, Visser MG, Vosselman MJ, et al. (2013) Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J Clin Invest 123(8):3395–3403
Liu X, Rossmeisl M, McClaine J, Riachi M, Harper ME, Kozak LP (2003) Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest 111(3):399–407
Butler AA, Kozak LP (2010) A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59(2):323–329
Schulz TJ, Huang P, Huang TL, Xue R, McDougall LE, Townsend KL, et al. (2013) Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat. Nature 495(7441):379–383
de Souza CJ, Hirshman MF, Horton ES (1997) CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes 46(8):1257–1263
Peirce V, Vidal-Puig A (2013) Regulation of glucose homoeostasis by brown adipose tissue. Lancet Diabetes Endocrinol 1(4):353–360
Lin L, Saha PK, Ma X, Henshaw IO, Shao L, Chang BH, et al. (2011) Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 10(6):996–1010
Tan CY, Vidal-Puig A (2008) Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 36(Pt 5):935–940
Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective. Biochim Biophys Acta 1801(3):338–349
Medina-Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 3(4):e64
Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, et al. (2008) Dynamics of fat cell turnover in humans. Nature 453(7196):783–787
Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, Chan G, et al. (2001) Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol 280(6):R1772–R1780
Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, et al. (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86(3):1020–1025
van Beek L, van Klinken JB, Pronk AC, van Dam AD, Dirven E, Rensen PC, et al. (2015) The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6 J mice. Diabetologia 58(7):1601–1609
Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117(9):2621–2637
Voigt A, Agnew K, van Schothorst EM, Keijer J, Klaus S (2013) Short-term, high fat feeding-induced changes in white adipose tissue gene expression are highly predictive for long-term changes. Mol Nutr Food Res 57(8):1423–1434
Nikonova L, Koza RA, Mendoza T, Chao PM, Curley JP, Kozak LP (2008) Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance. FASEB J: Off Publ Fed Am Soci Exp Biol 22(11):3925–3937
Kozak LP, Newman S, Chao PM, Mendoza T, Koza RA (2010b) The early nutritional environment of mice determines the capacity for adipose tissue expansion by modulating genes of caveolae structure. PLoS ONE 5(6):e11015
Takahashi M, Kamei Y, Ezaki O (2005) Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab 288(1):E117–E124
Jura M, Jaroslawska J, Chu DT, Kozak LP 2015 Mest and Sfrp5 are biomarkers for healthy adipose tissue. Biochimie
Rini J, Esko J, Varki A 2009 Glycosyltransferases and glycan-processing enzymes. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, et al., editors. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY)
Jung H, Lee SK, Jho EH (2011) Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation. Biochem J 436(2):263–269
Hulstrom V, Prats C, Vinten J (2013) Adipocyte size and cellular expression of caveolar proteins analyzed by confocal microscopy. Am J Physiol Cell Physiol 304(12):C1168–C1175
Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, et al. (1999) Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J: Off Publ Fed Am Soc Exp Biol 13(14):1961–1971
Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, et al. (2009) Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 29(6):1575–1591
Divoux A, Clement K (2011) Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev: Off J Int Asso Stud Obes 12(5):e494–e503
Rutkowski JM, Davis KE, Scherer PE (2009) Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 276(20):5738–5746
Acknowledgments
Support was provided by a grant to LPK from the Foundation for Polish Science, program WELCOME, no. WELCOME/2010-4/3 entitled “Nutrition and ambient temperature during early development can reduce susceptibility to obesity” financed by EU Structural Funds in Poland within the Innovative Economy Program and REFRESH project (FP7-REGPOT-2010-1-264103).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Jura, M., Kozak, L. Obesity and related consequences to ageing. AGE 38, 23 (2016). https://doi.org/10.1007/s11357-016-9884-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11357-016-9884-3
Keywords
- Metabolic syndrome
- Lean mass
- Brown adipose tissue
- Expandability